Investigator Site 40 - US0010003 — Chapel Hill, North Carolina

Investigator Site 40 - US0010003 is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site 40 - US0010003 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: argenx.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 40 - US0010003?

Investigator Site 40 - US0010003 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 40 - US0010003 conducted?

Investigator Site 40 - US0010003 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Investigator Site 40 - US0010003 accredited by Crixeo Clinical Trials?

Investigator Site 40 - US0010003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 40 - US0010003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.